Report-store Details

  • Home
  • Report-store Details
Contact Us
+1 (732) 526 1166
India: 040-46013143

info@sciinovgroup.com

Email Us

Report Type: Therapy Reports
Report Category: Women's Health
Report Subcategory: Atrophic Vaginitis or Vaginal Atrophy/Vulvovaginal Atrophy/Urogenital Atrophy
Price: 2999.00
Date: January 2022

Atrophic Vaginitis or Vaginal Atrophy/Vulvovaginal Atrophy/Urogenital Atrophy: Global Market Landscape till 2030 - Epidemiology, Drugs, Trials, Technology, Companies, News, Deals, Patents, Drug Sales & Forecast, Future Events, DMF, and Manufacturing

Atrophic Vaginitis or Vaginal Atrophy/Vulvovaginal Atrophy/Urogenital Atrophy
Atrophic Vaginitis or Vaginal Atrophy/Vulvovaginal Atrophy/Urogenital Atrophy is thinning, drying and inflammation of the vaginal walls that may occur when your body has less estrogen, most often after menopause.

Top 10 Companies:
Johnson & Johnson
Pfizer Inc
Bayer AG
Novartis AG
Novo Nordisk AS
Teva Pharmaceutical Industries Ltd
Shionogi & Co Ltd
Endo International Plc
Amneal Pharmaceuticals Inc
Hisamitsu Pharmaceutical Co Inc

Have a business Query? Let's Talk.

Email : info@sciinovgroup.com or Call : +1 (732) 526 1166
India: 040-46013143

Get The Latest Updates

Signup For Newsletter

(c) 2021 Sciinov Group - All rights reserved.